Evolent Health Sees Q4 Sales $227.5M-$239.5M vs $229.32M Est., Sees FY19 Sales $838M-$850M vs $837.62M Est.

From Earnings Report: "For the full year 2019, we are narrowing the range for Adjusted Revenue to be in the range of $838.0 million to $850.0 million. The components of Adjusted Revenue include Adjusted Services

Benzinga · 11/05/2019 21:10

From Earnings Report:

"For the full year 2019, we are narrowing the range for Adjusted Revenue to be in the range of $838.0 million to $850.0 million. The components of Adjusted Revenue include Adjusted Services Revenue, which is forecasted to be approximately $679.0 million to $689.0 million, and True Health premiums revenue, which is forecasted to be approximately $172.9 million to $174.9 million; intersegment eliminations are forecasted to be approximately $(13.7) million for the full year. We are forecasting Adjusted EBITDA to be in the range of $(11.1) million to $(8.1) million.

For the three months ending December 31, 2019, Adjusted Revenue is expected to be in the range of approximately $227.5 million to $239.5 million. The components of Adjusted Revenue include Adjusted Services Revenue, which is forecasted to be approximately $195.0 million to $205.0 million, and True Health premiums revenue, which is forecasted to be approximately $36.0 million to $38.0 million; intersegment eliminations are forecasted to be approximately $(3.5) million for the quarter. Adjusted EBITDA is expected to be in the range of approximately $8.0 million to $11.0 million."